RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,690,986 | -11.6% | 1,244,945 | -0.5% | 0.44% | +3.8% |
| Q2 2023 | $23,395,009 | +1.9% | 1,251,070 | 0.0% | 0.42% | -6.0% |
| Q1 2023 | $22,957,135 | -7.3% | 1,251,070 | 0.0% | 0.45% | -4.9% |
| Q4 2022 | $24,771,186 | -17.7% | 1,251,070 | 0.0% | 0.47% | -15.2% |
| Q3 2022 | $30,101,000 | +90.4% | 1,251,070 | +44.4% | 0.56% | +94.8% |
| Q2 2022 | $15,812,000 | +99.0% | 866,396 | +139.8% | 0.29% | +122.5% |
| Q1 2022 | $7,945,000 | -0.3% | 361,300 | +66.5% | 0.13% | +26.5% |
| Q4 2021 | $7,970,000 | – | 217,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |